Skip to main content

Table 1 Number of samples in each class in discovery and validation cohorts

From: Probabilistic modeling methods for cell-free DNA methylation based cancer classification

Class Discovery cohort Validation cohort
Healthy controls (normal) 24 62
Renal cancer (RCC) 20
Pancreatic ductal adenocarcinoma (PDAC) 24 47
Colorectal cancer (CRC) 23
Bladder cancer (BLCA) 20
Breast cancer (BRCA) 25
Lung cancer (LUC) 25 55
Acute myeloid leukemia (AML) 28 35
Total 189 199